 | • レポートコード：MRC2312MG03870 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥468,000 (USD3,250) | ▷ お問い合わせ |
| Multi User | ￥608,400 (USD4,225) | ▷ お問い合わせ |
| Enterprise User | ￥702,000 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Global Avian Pox Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるの鳥痘ワクチン市場規模と予測を収録しています。 ・世界の鳥痘ワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界の鳥痘ワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の鳥痘ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「水痘ワクチン水痘弱毒化ウイルスワクチン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。 鳥痘ワクチンのグローバル主要企業は、Boehringer-Ingelheim、 Living BP、 Zoetis、 Bio-Med、 MSD Animal Health、 HIPRA、 Vetvaco、 KBNP、 Hygieia、 Agrikhub、 Harbin Pharmaceutical Group、 Shandong Lvdu、 Zhejiang Nuobeiweiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル社は、鳥痘ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別マーケット分析】 世界の鳥痘ワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界の鳥痘ワクチン市場：タイプ別市場シェア、2022年 ・水痘ワクチン水痘弱毒化ウイルスワクチン、水痘タンパク質グルテン弱毒化ワクチン（鶏痘オリジナル）、水痘タンパク質グルテン弱毒化ワクチン（ハト痘由来） 世界の鳥痘ワクチン市場：用途別、2018年-2023年、2024年-2029年 世界の鳥痘ワクチン市場：用途別市場シェア、2022年 ・鶏肉、成鶏 世界の鳥痘ワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界の鳥痘ワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競争分析】 また、当レポートは主要な参入企業の分析を提供します。 ・主要企業における鳥痘ワクチンのグローバル売上、2018年-2023年 ・主要企業における鳥痘ワクチンのグローバル売上シェア、2022年 ・主要企業における鳥痘ワクチンのグローバル販売量、2018年-2023年 ・主要企業における鳥痘ワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業の情報を提示します。 Boehringer-Ingelheim、 Living BP、 Zoetis、 Bio-Med、 MSD Animal Health、 HIPRA、 Vetvaco、 KBNP、 Hygieia、 Agrikhub、 Harbin Pharmaceutical Group、 Shandong Lvdu、 Zhejiang Nuobeiwei ************************************************************* ・調査・分析レポートの概要 鳥痘ワクチン市場の定義 市場セグメント 世界の鳥痘ワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の鳥痘ワクチン市場規模 世界の鳥痘ワクチン市場規模：2022年 VS 2029年 世界の鳥痘ワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの鳥痘ワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の鳥痘ワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：水痘ワクチン水痘弱毒化ウイルスワクチン、水痘タンパク質グルテン弱毒化ワクチン（鶏痘オリジナル）、水痘タンパク質グルテン弱毒化ワクチン（ハト痘由来） 鳥痘ワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：鶏肉、成鶏 鳥痘ワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別鳥痘ワクチン市場規模 2022年と2029年 地域別鳥痘ワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど） Boehringer-Ingelheim、 Living BP、 Zoetis、 Bio-Med、 MSD Animal Health、 HIPRA、 Vetvaco、 KBNP、 Hygieia、 Agrikhub、 Harbin Pharmaceutical Group、 Shandong Lvdu、 Zhejiang Nuobeiwei ... |
This research report provides a comprehensive analysis of the Avian Pox Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Avian Pox Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Avian Pox Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Avian Pox Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Avian Pox Vaccine market presents opportunities for various stakeholders, including Chicken, Adult Chicken. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Avian Pox Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Avian Pox Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Avian Pox Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Avian Pox Vaccine market.
Market Overview: The report provides a comprehensive overview of the Avian Pox Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Chicken Pox Vaccine Chicken Pox Quailized Attenuated Virus Vaccine, Chickenpox Protein Gluten Attenuated Vaccine (Fowlpox Original)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Avian Pox Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Avian Pox Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Avian Pox Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Avian Pox Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Avian Pox Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Avian Pox Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Avian Pox Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Avian Pox Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Avian Pox Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chicken Pox Vaccine Chicken Pox Quailized Attenuated Virus Vaccine
Chickenpox Protein Gluten Attenuated Vaccine (Fowlpox Original)
Chicken Pox Protein Gluten Attenuated Vaccine (Pigeon Pox Origin)
Market segment by Application
Chicken
Adult Chicken
Global Avian Pox Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Boehringer-Ingelheim
Living BP
Zoetis
Bio-Med
MSD Animal Health
HIPRA
Vetvaco
KBNP
Hygieia
Agrikhub
Harbin Pharmaceutical Group
Shandong Lvdu
Zhejiang Nuobeiwei
Outline of Major Chapters:
Chapter 1: Introduces the definition of Avian Pox Vaccine, market overview.
Chapter 2: Global Avian Pox Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Avian Pox Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Avian Pox Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Avian Pox Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Avian Pox Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Avian Pox Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Avian Pox Vaccine Overall Market Size
2.1 Global Avian Pox Vaccine Market Size: 2022 VS 2029
2.2 Global Avian Pox Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Avian Pox Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Avian Pox Vaccine Players in Global Market
3.2 Top Global Avian Pox Vaccine Companies Ranked by Revenue
3.3 Global Avian Pox Vaccine Revenue by Companies
3.4 Global Avian Pox Vaccine Sales by Companies
3.5 Global Avian Pox Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Avian Pox Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Avian Pox Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Avian Pox Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Avian Pox Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Avian Pox Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Avian Pox Vaccine Market Size Markets, 2022 & 2029
4.1.2 Chicken Pox Vaccine Chicken Pox Quailized Attenuated Virus Vaccine
4.1.3 Chickenpox Protein Gluten Attenuated Vaccine (Fowlpox Original)
4.1.4 Chicken Pox Protein Gluten Attenuated Vaccine (Pigeon Pox Origin)
4.2 By Type – Global Avian Pox Vaccine Revenue & Forecasts
4.2.1 By Type – Global Avian Pox Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Avian Pox Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Avian Pox Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Avian Pox Vaccine Sales & Forecasts
4.3.1 By Type – Global Avian Pox Vaccine Sales, 2018-2023
4.3.2 By Type – Global Avian Pox Vaccine Sales, 2024-2029
4.3.3 By Type – Global Avian Pox Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Avian Pox Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Avian Pox Vaccine Market Size, 2022 & 2029
5.1.2 Chicken
5.1.3 Adult Chicken
5.2 By Application – Global Avian Pox Vaccine Revenue & Forecasts
5.2.1 By Application – Global Avian Pox Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Avian Pox Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Avian Pox Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Avian Pox Vaccine Sales & Forecasts
5.3.1 By Application – Global Avian Pox Vaccine Sales, 2018-2023
5.3.2 By Application – Global Avian Pox Vaccine Sales, 2024-2029
5.3.3 By Application – Global Avian Pox Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Avian Pox Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Avian Pox Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Avian Pox Vaccine Revenue & Forecasts
6.2.1 By Region – Global Avian Pox Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Avian Pox Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Avian Pox Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Avian Pox Vaccine Sales & Forecasts
6.3.1 By Region – Global Avian Pox Vaccine Sales, 2018-2023
6.3.2 By Region – Global Avian Pox Vaccine Sales, 2024-2029
6.3.3 By Region – Global Avian Pox Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Avian Pox Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Avian Pox Vaccine Sales, 2018-2029
6.4.3 US Avian Pox Vaccine Market Size, 2018-2029
6.4.4 Canada Avian Pox Vaccine Market Size, 2018-2029
6.4.5 Mexico Avian Pox Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Avian Pox Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Avian Pox Vaccine Sales, 2018-2029
6.5.3 Germany Avian Pox Vaccine Market Size, 2018-2029
6.5.4 France Avian Pox Vaccine Market Size, 2018-2029
6.5.5 U.K. Avian Pox Vaccine Market Size, 2018-2029
6.5.6 Italy Avian Pox Vaccine Market Size, 2018-2029
6.5.7 Russia Avian Pox Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Avian Pox Vaccine Market Size, 2018-2029
6.5.9 Benelux Avian Pox Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Avian Pox Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Avian Pox Vaccine Sales, 2018-2029
6.6.3 China Avian Pox Vaccine Market Size, 2018-2029
6.6.4 Japan Avian Pox Vaccine Market Size, 2018-2029
6.6.5 South Korea Avian Pox Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Avian Pox Vaccine Market Size, 2018-2029
6.6.7 India Avian Pox Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Avian Pox Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Avian Pox Vaccine Sales, 2018-2029
6.7.3 Brazil Avian Pox Vaccine Market Size, 2018-2029
6.7.4 Argentina Avian Pox Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Avian Pox Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Avian Pox Vaccine Sales, 2018-2029
6.8.3 Turkey Avian Pox Vaccine Market Size, 2018-2029
6.8.4 Israel Avian Pox Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Avian Pox Vaccine Market Size, 2018-2029
6.8.6 UAE Avian Pox Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Boehringer-Ingelheim
7.1.1 Boehringer-Ingelheim Company Summary
7.1.2 Boehringer-Ingelheim Business Overview
7.1.3 Boehringer-Ingelheim Avian Pox Vaccine Major Product Offerings
7.1.4 Boehringer-Ingelheim Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Boehringer-Ingelheim Key News & Latest Developments
7.2 Living BP
7.2.1 Living BP Company Summary
7.2.2 Living BP Business Overview
7.2.3 Living BP Avian Pox Vaccine Major Product Offerings
7.2.4 Living BP Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Living BP Key News & Latest Developments
7.3 Zoetis
7.3.1 Zoetis Company Summary
7.3.2 Zoetis Business Overview
7.3.3 Zoetis Avian Pox Vaccine Major Product Offerings
7.3.4 Zoetis Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Zoetis Key News & Latest Developments
7.4 Bio-Med
7.4.1 Bio-Med Company Summary
7.4.2 Bio-Med Business Overview
7.4.3 Bio-Med Avian Pox Vaccine Major Product Offerings
7.4.4 Bio-Med Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Bio-Med Key News & Latest Developments
7.5 MSD Animal Health
7.5.1 MSD Animal Health Company Summary
7.5.2 MSD Animal Health Business Overview
7.5.3 MSD Animal Health Avian Pox Vaccine Major Product Offerings
7.5.4 MSD Animal Health Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 MSD Animal Health Key News & Latest Developments
7.6 HIPRA
7.6.1 HIPRA Company Summary
7.6.2 HIPRA Business Overview
7.6.3 HIPRA Avian Pox Vaccine Major Product Offerings
7.6.4 HIPRA Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 HIPRA Key News & Latest Developments
7.7 Vetvaco
7.7.1 Vetvaco Company Summary
7.7.2 Vetvaco Business Overview
7.7.3 Vetvaco Avian Pox Vaccine Major Product Offerings
7.7.4 Vetvaco Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Vetvaco Key News & Latest Developments
7.8 KBNP
7.8.1 KBNP Company Summary
7.8.2 KBNP Business Overview
7.8.3 KBNP Avian Pox Vaccine Major Product Offerings
7.8.4 KBNP Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 KBNP Key News & Latest Developments
7.9 Hygieia
7.9.1 Hygieia Company Summary
7.9.2 Hygieia Business Overview
7.9.3 Hygieia Avian Pox Vaccine Major Product Offerings
7.9.4 Hygieia Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Hygieia Key News & Latest Developments
7.10 Agrikhub
7.10.1 Agrikhub Company Summary
7.10.2 Agrikhub Business Overview
7.10.3 Agrikhub Avian Pox Vaccine Major Product Offerings
7.10.4 Agrikhub Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Agrikhub Key News & Latest Developments
7.11 Harbin Pharmaceutical Group
7.11.1 Harbin Pharmaceutical Group Company Summary
7.11.2 Harbin Pharmaceutical Group Business Overview
7.11.3 Harbin Pharmaceutical Group Avian Pox Vaccine Major Product Offerings
7.11.4 Harbin Pharmaceutical Group Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Harbin Pharmaceutical Group Key News & Latest Developments
7.12 Shandong Lvdu
7.12.1 Shandong Lvdu Company Summary
7.12.2 Shandong Lvdu Business Overview
7.12.3 Shandong Lvdu Avian Pox Vaccine Major Product Offerings
7.12.4 Shandong Lvdu Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Shandong Lvdu Key News & Latest Developments
7.13 Zhejiang Nuobeiwei
7.13.1 Zhejiang Nuobeiwei Company Summary
7.13.2 Zhejiang Nuobeiwei Business Overview
7.13.3 Zhejiang Nuobeiwei Avian Pox Vaccine Major Product Offerings
7.13.4 Zhejiang Nuobeiwei Avian Pox Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Zhejiang Nuobeiwei Key News & Latest Developments
8 Global Avian Pox Vaccine Production Capacity, Analysis
8.1 Global Avian Pox Vaccine Production Capacity, 2018-2029
8.2 Avian Pox Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Avian Pox Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Avian Pox Vaccine Supply Chain Analysis
10.1 Avian Pox Vaccine Industry Value Chain
10.2 Avian Pox Vaccine Upstream Market
10.3 Avian Pox Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Avian Pox Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Avian Pox Vaccine in Global Market
Table 2. Top Avian Pox Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Avian Pox Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Avian Pox Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Avian Pox Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Avian Pox Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Avian Pox Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Avian Pox Vaccine Product Type
Table 9. List of Global Tier 1 Avian Pox Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Avian Pox Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Avian Pox Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Avian Pox Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Avian Pox Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Avian Pox Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Avian Pox Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Avian Pox Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Avian Pox Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Avian Pox Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Avian Pox Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Avian Pox Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Avian Pox Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Avian Pox Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Avian Pox Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Avian Pox Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Avian Pox Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Avian Pox Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Avian Pox Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Avian Pox Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Avian Pox Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Avian Pox Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Avian Pox Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Avian Pox Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Avian Pox Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Avian Pox Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Avian Pox Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Avian Pox Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Avian Pox Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Avian Pox Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Avian Pox Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Avian Pox Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Avian Pox Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Avian Pox Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Avian Pox Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Avian Pox Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Avian Pox Vaccine Sales, (K Units), 2024-2029
Table 46. Boehringer-Ingelheim Company Summary
Table 47. Boehringer-Ingelheim Avian Pox Vaccine Product Offerings
Table 48. Boehringer-Ingelheim Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Boehringer-Ingelheim Key News & Latest Developments
Table 50. Living BP Company Summary
Table 51. Living BP Avian Pox Vaccine Product Offerings
Table 52. Living BP Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Living BP Key News & Latest Developments
Table 54. Zoetis Company Summary
Table 55. Zoetis Avian Pox Vaccine Product Offerings
Table 56. Zoetis Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Zoetis Key News & Latest Developments
Table 58. Bio-Med Company Summary
Table 59. Bio-Med Avian Pox Vaccine Product Offerings
Table 60. Bio-Med Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Bio-Med Key News & Latest Developments
Table 62. MSD Animal Health Company Summary
Table 63. MSD Animal Health Avian Pox Vaccine Product Offerings
Table 64. MSD Animal Health Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. MSD Animal Health Key News & Latest Developments
Table 66. HIPRA Company Summary
Table 67. HIPRA Avian Pox Vaccine Product Offerings
Table 68. HIPRA Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. HIPRA Key News & Latest Developments
Table 70. Vetvaco Company Summary
Table 71. Vetvaco Avian Pox Vaccine Product Offerings
Table 72. Vetvaco Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Vetvaco Key News & Latest Developments
Table 74. KBNP Company Summary
Table 75. KBNP Avian Pox Vaccine Product Offerings
Table 76. KBNP Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. KBNP Key News & Latest Developments
Table 78. Hygieia Company Summary
Table 79. Hygieia Avian Pox Vaccine Product Offerings
Table 80. Hygieia Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Hygieia Key News & Latest Developments
Table 82. Agrikhub Company Summary
Table 83. Agrikhub Avian Pox Vaccine Product Offerings
Table 84. Agrikhub Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Agrikhub Key News & Latest Developments
Table 86. Harbin Pharmaceutical Group Company Summary
Table 87. Harbin Pharmaceutical Group Avian Pox Vaccine Product Offerings
Table 88. Harbin Pharmaceutical Group Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Harbin Pharmaceutical Group Key News & Latest Developments
Table 90. Shandong Lvdu Company Summary
Table 91. Shandong Lvdu Avian Pox Vaccine Product Offerings
Table 92. Shandong Lvdu Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Shandong Lvdu Key News & Latest Developments
Table 94. Zhejiang Nuobeiwei Company Summary
Table 95. Zhejiang Nuobeiwei Avian Pox Vaccine Product Offerings
Table 96. Zhejiang Nuobeiwei Avian Pox Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Zhejiang Nuobeiwei Key News & Latest Developments
Table 98. Avian Pox Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Avian Pox Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Avian Pox Vaccine Production by Region, 2018-2023 (K Units)
Table 101. Global Avian Pox Vaccine Production by Region, 2024-2029 (K Units)
Table 102. Avian Pox Vaccine Market Opportunities & Trends in Global Market
Table 103. Avian Pox Vaccine Market Drivers in Global Market
Table 104. Avian Pox Vaccine Market Restraints in Global Market
Table 105. Avian Pox Vaccine Raw Materials
Table 106. Avian Pox Vaccine Raw Materials Suppliers in Global Market
Table 107. Typical Avian Pox Vaccine Downstream
Table 108. Avian Pox Vaccine Downstream Clients in Global Market
Table 109. Avian Pox Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Avian Pox Vaccine Segment by Type in 2022
Figure 2. Avian Pox Vaccine Segment by Application in 2022
Figure 3. Global Avian Pox Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Avian Pox Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Avian Pox Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Avian Pox Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Avian Pox Vaccine Revenue in 2022
Figure 9. By Type - Global Avian Pox Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Avian Pox Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Avian Pox Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Avian Pox Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Avian Pox Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Avian Pox Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Avian Pox Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Avian Pox Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Avian Pox Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Avian Pox Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Avian Pox Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Avian Pox Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Avian Pox Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Avian Pox Vaccine Sales Market Share, 2018-2029
Figure 23. US Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Avian Pox Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Avian Pox Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Avian Pox Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Avian Pox Vaccine Sales Market Share, 2018-2029
Figure 37. China Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Avian Pox Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Avian Pox Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Avian Pox Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Avian Pox Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Avian Pox Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Avian Pox Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Avian Pox Vaccine by Region, 2022 VS 2029
Figure 54. Avian Pox Vaccine Industry Value Chain
Figure 55. Marketing Channels
• 日本語訳：世界の鳥痘ワクチン市場予測2023-2029：水痘ワクチン水痘弱毒化ウイルスワクチン、水痘タンパク質グルテン弱毒化ワクチン（鶏痘オリジナル）、水痘タンパク質グルテン弱毒化ワクチン（ハト痘由来）
• レポートコード：MRC2312MG03870 ▷ お問い合わせ（見積依頼・ご注文・質問）